About: Clinical impact of rapid molecular detection of respiratory pathogens in patients with acute respiratory infection

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Clinical impact of rapid molecular detection of respiratory pathogens in patients with acute respiratory infection Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Clinical impact of rapid molecular detection of respiratory pathogens in patients with acute respiratory infection
Creator	Carballal, G Echavarría, M Ekstrom, J Marcone, D O'farrell, C Querci, M Seoane, A Vidaurreta, S Videla, C Ypas, M
Source	Elsevier; Medline; PMC
abstract	BACKGROUND: Acute respiratory infections (ARI) are a leading cause of morbidity and mortality worldwide. There is a need to demonstrate the clinical impact of using the new, rapid and sensitive molecular assays in prospectively designed studies. OBJECTIVES: To study the impact on medical management of a rapid molecular assay in patients with respiratory infections. STUDY DESIGN: A prospective, randomized, non-blinded study was performed in patients presenting to the Emergency Department during two respiratory seasons (2016–2017). Diagnosis was performed by FilmArray Respiratory Panel (FilmArray-RP) or by immunofluorescence assay (IFA). RESULTS: A total of 432 patients (156 children and 276 adults) were analyzed. Diagnosis with FilmArray-RP was associated with significant changes in medical management including withholding antibiotic prescriptions (OR:15.52, 95%CI:1.99–120.83 in adults and OR:12.23, 95%CI:1.56–96.09 in children), and reduction in complementary studies in children (OR:9.64, 95%CI:2.13–43.63) compared to IFA. Decrease in oseltamivir prescriptions was significantly higher in adults in the FilmArray-RP group (p = 0.042; OR:1.19, 95%CI:0.51-2.79) compared to adults managed with IFA. Diagnostic yield was significantly higher by FilmArray-RP (81%) than by IFA (31%)(p < 0.001). The median time from sample collection to reporting was 1 h 52 min by FilmArray-RP and 26 h by IFA (p < 0.001). CONCLUSIONS: The high respiratory viruses’ detection rate and availability of results within two hours when using FilmArray-RP were associated with decreases in antibiotic prescriptions and complementary studies and more accurate use of oseltamivir.
has issue date	2018-09-14(xsd:dateTime)
bibo:doi	10.1016/j.jcv.2018.09.009
bibo:pmid	30267999
has license	no-cc
sha1sum (hex)	6590855e7d8b1204c516d46ce501f9fe86345057
schema:url	https://doi.org/10.1016/j.jcv.2018.09.009
resource representing a document's title	Clinical impact of rapid molecular detection of respiratory pathogens in patients with acute respiratory infection
has PubMed Central identifier	PMC7172208
has PubMed identifier	30267999
schema:publication	J Clin Virol
resource representing a document's body	covid:6590855e7d8b1204c516d46ce501f9fe86345057#body_text
is schema:about of	named entity 'IFA' named entity 'patients' named entity 'managed' named entity 'Objectives' named entity 'yield' named entity 'leading' named entity 'CHANGES' named entity 'NEED' named entity 'PRESENTING' named entity '0.042' named entity 'SIGNIFICANT' named entity 'There' named entity 'studies' named entity 'respiratory infections' named entity 'Panel' named entity 'availability' named entity 'statistically significant' named entity 'radiographs' named entity 'antibiotics' named entity 'coinfections' named entity 'antibiotics' named entity 'viruses' named entity 'odds ratios' named entity 'oseltamivir' named entity 'intention to treat' named entity 'antibiotics' named entity 'coinfections' named entity 'cardiac disease' named entity 'Stata' named entity 'pediatricians' named entity 'public health' named entity 'viruses' named entity 'influenza' named entity 'viruses' named entity 'signs/symptoms' named entity 'viral infection' named entity 'viruses' named entity 'M. pneumoniae' named entity 'bronchitis' named entity 'viruses' named entity 'Bordetella pertussis' named entity 'demographic data' named entity 'viruses' named entity 'statistically significant' named entity 'ALRI' named entity 'antibiotic' named entity 'antigen' named entity 'Buenos Aires' named entity 'diagnostic test' named entity 'neurological' named entity 'viral load' named entity 'real-time PCR' named entity 'odds ratios' named entity 'coronaviruses' named entity 'chronic obstructive pulmonary disease' named entity 'Chlamydia pneumoniae' named entity 'informed consent' named entity 'compared' named entity 'presenting' named entity 'performed' named entity 'sample' named entity 'adults' named entity 'detection' named entity 'Diagnosis' named entity 'influenza' named entity 'viruses' named entity 'pediatric' named entity 'rapid diagnostic tests' named entity 'oseltamivir' named entity 'Demographic' named entity 'oxygen therapy' named entity 'antibiotic'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software